Stephen Gowing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stephen Gowing has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Alexandre Tran
Division of General Surgery, Department of Surgery, The Ottawa Hospital, Ottawa, Canada
2 shared publications- Andrew John Ervine Seely
Ottawa Hospital Research Institute, Ottawa, Canada
2 shared publications Caitlin Anstee
Division of Thoracic Surgery, Department of Surgery, The Ottawa Hospital, Ottawa, Canada
2 shared publicationsDonna E. Maziak
Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada
2 shared publicationsEmma Grigor
Faculty of Medicine, The University of Ottawa, Ottawa, Canada
2 shared publicationsFarid Shamji
Division of Thoracic Surgery, Department of Surgery, The Ottawa Hospital, Ottawa, Canada
2 shared publications
Latest Publications
- 4 November 2023
- Published by Springer Nature
- p. 31-45
Endoscopy and Endoscopic Ultrasound for Esophageal Cancer
- 4 November 2023
- Published by Springer Nature
- p. 31-45
Endoscopy and Endoscopic Ultrasound for Esophageal Cancer
- 15 November 2020
- Published by Springer Nature in Lung
- Vol. 198 (6) , 983
Correction to: Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative‑intent Resection for Lung Cancer
The original version of this article unfortunately contained a mistake in author names. The given and family names of all the authors was transposed. The a
- 15 November 2020
- Published by Springer Nature in Lung
- Vol. 198 (6) , 983
Correction to: Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative‑intent Resection for Lung Cancer
The original version of this article unfortunately contained a mistake in author names. The given and family names of all the authors was transposed. The a
- 9 October 2020
- Published by Springer Nature in Lung
- Vol. 198 (6) , 973-981
Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative-intent Resection for Lung Cancer
Background Up to 50% of patients suffer short-term postoperative adverse events (AEs) and metastatic recurrence in the long-term following curative-intent lung cancer resection. The association between AEs, particularly infectious in nature, and disease recurrence is controversial. We sought to evaluate the association of postoperative AEs on risk of developing recurrence and recurrence-free survival (RFS) following curative-intent lung resection surgery. Methods All lung cancer resections at a single institution (January 2008–July 2015) were included, with prospective collection of AEs using the Thoracic Morbidity & Mortality System. Cox proportional hazards models were used to estimate the effect of AEs on recurrence, with results presented as hazard ratio (HR) with 95% confidence interval (CI). An a priori, clinically driven approach to predictor variable selection was used. Kaplan–Meier curves were used examine the relationship between AE and RFS. p < 0.05 was considered statistically significant. Results 892 patients underwent curative-intent resection. 342 (38.3%) patients experienced an AE; 69 (7.7%) patients developed infectious AEs. 17.6% (n = 157) of patients had disease recurrence after mean follow-up of 26.5 months. Severe (Grade IV) AEs were associated with increased risk of recurrence (3.40; 95% CI 1.56–7.41) and a trend to decreased RFS. Major infectious AEs were associated with increased risk of recurrence (HR 1.71; CI 1.05–2.8) and earlier time to recurrence (no infectious AE 66 months, minor infectious 41 months, major infectious 54 months; p = 0.02). Conclusion For patients undergoing curative-intent lung cancer resection, postoperative AEs associated with critical illness or major infection were associated with increased risk of oncologic recurrence.
- 9 October 2020
- Published by Springer Nature in Lung
- Vol. 198 (6) , 973-981
Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative-intent Resection for Lung Cancer
Background Up to 50% of patients suffer short-term postoperative adverse events (AEs) and metastatic recurrence in the long-term following curative-intent lung cancer resection. The association between AEs, particularly infectious in nature, and disease recurrence is controversial. We sought to evaluate the association of postoperative AEs on risk of developing recurrence and recurrence-free survival (RFS) following curative-intent lung resection surgery. Methods All lung cancer resections at a single institution (January 2008–July 2015) were included, with prospective collection of AEs using the Thoracic Morbidity & Mortality System. Cox proportional hazards models were used to estimate the effect of AEs on recurrence, with results presented as hazard ratio (HR) with 95% confidence interval (CI). An a priori, clinically driven approach to predictor variable selection was used. Kaplan–Meier curves were used examine the relationship between AE and RFS. p < 0.05 was considered statistically significant. Results 892 patients underwent curative-intent resection. 342 (38.3%) patients experienced an AE; 69 (7.7%) patients developed infectious AEs. 17.6% (n = 157) of patients had disease recurrence after mean follow-up of 26.5 months. Severe (Grade IV) AEs were associated with increased risk of recurrence (3.40; 95% CI 1.56–7.41) and a trend to decreased RFS. Major infectious AEs were associated with increased risk of recurrence (HR 1.71; CI 1.05–2.8) and earlier time to recurrence (no infectious AE 66 months, minor infectious 41 months, major infectious 54 months; p = 0.02). Conclusion For patients undergoing curative-intent lung cancer resection, postoperative AEs associated with critical illness or major infection were associated with increased risk of oncologic recurrence.
- 23 January 2020
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 37 (2) , 225-239
Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence
Cancer is the leading cause of death in North America. Despite modern advances in cancer therapy, many patients will ultimately develop cancer metastasis resulting in mortality. Surgery to resect early stage solid malignancies remains the cornerstone of cancer treatment. However, surgery places patients at risk of developing post-operative infectious complications that are linked to earlier cancer metastatic recurrence and cancer mortality. Toll-like receptors (TLRs) are evolutionarily-conserved sentinel receptors of the innate immune system that are activated by microbial products present during infection, leading to activation of innate immunity. Numerous types of solid cancer cells also express TLRs, with their activation augmenting their ability to metastasize. Similarly, healthy host-tissue TLRs activated during infection induce a prometastatic environment in the host. Cancer cells additionally secrete TLR activating ligands that activate both cancer TLRs and host TLRs to promote metastasis. Consequently, TLRs are an attractive therapeutic candidate to target infection-induced cancer metastasis and progression.
- 23 January 2020
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 37 (2) , 225-239
Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence
Cancer is the leading cause of death in North America. Despite modern advances in cancer therapy, many patients will ultimately develop cancer metastasis resulting in mortality. Surgery to resect early stage solid malignancies remains the cornerstone of cancer treatment. However, surgery places patients at risk of developing post-operative infectious complications that are linked to earlier cancer metastatic recurrence and cancer mortality. Toll-like receptors (TLRs) are evolutionarily-conserved sentinel receptors of the innate immune system that are activated by microbial products present during infection, leading to activation of innate immunity. Numerous types of solid cancer cells also express TLRs, with their activation augmenting their ability to metastasize. Similarly, healthy host-tissue TLRs activated during infection induce a prometastatic environment in the host. Cancer cells additionally secrete TLR activating ligands that activate both cancer TLRs and host TLRs to promote metastasis. Consequently, TLRs are an attractive therapeutic candidate to target infection-induced cancer metastasis and progression.
- 12 April 2017
- Published by Wiley in International Journal of Cancer
- Vol. 141 (3) , 561-571
Gram-positive pneumonia augments non-small cell lung cancer metastasisviahost toll-like receptor 2 activation
Surgical resection of early stage nonsmall cell lung cancer (NSCLC) is necessary for cure. However, rates of postoperative bacterial pneumonias remain high and may confer an increased risk for metastasis. Toll‐like receptors (TLRs) mediate the inflammatory cascade by recognizing microbial products at the surface of numerous cell types in the lung; however, little is known about how host TLRs influence NSCLC metastasis. TLR2 recognizes gram‐positive bacterial cell wall components activating innate immunity. We demonstrate that lower respiratory tract infection with Streptococcus pneumonia augments the formation of murine H59 NSCLC liver metastases in C57BL/6 mice through host TLR2 activation. Infected mice demonstrate increased H59 and human A549 NSCLC adhesion to hepatic sinusoids in vivo compared with noninfected controls, a response that is significantly diminished in TLR2 knock‐out mice. Intra‐tracheal injection of purified TLR2 ligand lipoteichoic acid into mice similarly augments in vivo adhesion of H59 cells to hepatic sinusoids. Additionally, H59 and A549 NSCLC cells incubated with bronchoepithelial conditioned media show increased cell adhesion to extracellular matrix components in vitro and hepatic sinusoids in vivo in a manner that is dependent on bronchoepithelial TLR2 activation and interleukin‐6 secretion. TLR2 is therefore a potential therapeutic target for gram‐positive pneumonia‐driven NSCLC metastasis.
- 12 April 2017
- Published by Wiley in International Journal of Cancer
- Vol. 141 (3) , 561-571
Gram-positive pneumonia augments non-small cell lung cancer metastasisviahost toll-like receptor 2 activation
Surgical resection of early stage nonsmall cell lung cancer (NSCLC) is necessary for cure. However, rates of postoperative bacterial pneumonias remain high and may confer an increased risk for metastasis. Toll‐like receptors (TLRs) mediate the inflammatory cascade by recognizing microbial products at the surface of numerous cell types in the lung; however, little is known about how host TLRs influence NSCLC metastasis. TLR2 recognizes gram‐positive bacterial cell wall components activating innate immunity. We demonstrate that lower respiratory tract infection with Streptococcus pneumonia augments the formation of murine H59 NSCLC liver metastases in C57BL/6 mice through host TLR2 activation. Infected mice demonstrate increased H59 and human A549 NSCLC adhesion to hepatic sinusoids in vivo compared with noninfected controls, a response that is significantly diminished in TLR2 knock‐out mice. Intra‐tracheal injection of purified TLR2 ligand lipoteichoic acid into mice similarly augments in vivo adhesion of H59 cells to hepatic sinusoids. Additionally, H59 and A549 NSCLC cells incubated with bronchoepithelial conditioned media show increased cell adhesion to extracellular matrix components in vitro and hepatic sinusoids in vivo in a manner that is dependent on bronchoepithelial TLR2 activation and interleukin‐6 secretion. TLR2 is therefore a potential therapeutic target for gram‐positive pneumonia‐driven NSCLC metastasis.
- 8 March 2016
- Published by Wiley in World Journal of Surgery
- Vol. 40 (6) , 1390-1396
Evolving Management of Zenker’s Diverticulum in the Endoscopic Era: A North American Experience
Background: Open surgical cricopharyngeal myotomy(CM) is considered standard of care for Zenker’s diverticulum(ZD). Trans‐oral CM has been described using a rigid stapling device for two decades; however, this remains problematic for severely kyphotic patients. This problem can be overcome with flexible endoscopy utilizing an electrosurgical needle knife. We sought to compare clinical outcomes between these techniques to stratify patient selection.Methods: Patients undergoing ZD treatment from 1992 to 2015 were reviewed. Demographics, diverticulum size, post‐operative complications, and length of stay (LOS) were compared between open cricopharyngeal myotomy (OpenCM), rigid trans‐oral stapling myotomy (RigidCM), and flexible endoscopic myotomy (FlexCM). Dysphagia scores (DS, 0:best‐4:worst) and pneumonia incidence were assessed pre‐operatively and post‐operatively.Results: 62 patients underwent OpenCM (39/62(63 %)) or endoscopic CM (23/62(37 %) (8 RigidCM/15 FlexCM)). CM significantly reduced dysphagia for all approaches [OpenCM:2(2‐3)‐0(0‐0); RigidCM:2(2‐2)‐0(0‐0); FlexCM:3(3‐3)‐0(0‐0)]. FlexCM patients had significantly worse pre‐operative DS. Endoscopic CM was attempted and completed in 23/35(66 %) patients. Reasons for OpenCM conversion included inability to position the diverticular retractor due to patient body habitus (RigidCM), and the inability to position the overtube due to small ZD (FlexCM). Major post‐operative complications were rare and similar in all groups. Medium‐to‐long‐term post‐myotomy pneumonia was comparable between groups. LOS (days) was reduced for FlexCM (1(1‐2)) versus RigidCM (3(2‐6)) and OpenCM (4(3‐7)).Conclusions: CM is highly effective for treating ZD. Open and endoscopic approaches offer comparable outcomes and dysphagia resolution. FlexCM is efficacious for large ZD and can be performed in most patients irrespective of body habitus. FlexCM represents an excellent approach for large ZD, while OpenCM should be reserved for small ZD for which an overtube cannot be positioned.
- 8 March 2016
- Published by Wiley in World Journal of Surgery
- Vol. 40 (6) , 1390-1396
Evolving Management of Zenker’s Diverticulum in the Endoscopic Era: A North American Experience
Background: Open surgical cricopharyngeal myotomy(CM) is considered standard of care for Zenker’s diverticulum(ZD). Trans‐oral CM has been described using a rigid stapling device for two decades; however, this remains problematic for severely kyphotic patients. This problem can be overcome with flexible endoscopy utilizing an electrosurgical needle knife. We sought to compare clinical outcomes between these techniques to stratify patient selection.Methods: Patients undergoing ZD treatment from 1992 to 2015 were reviewed. Demographics, diverticulum size, post‐operative complications, and length of stay (LOS) were compared between open cricopharyngeal myotomy (OpenCM), rigid trans‐oral stapling myotomy (RigidCM), and flexible endoscopic myotomy (FlexCM). Dysphagia scores (DS, 0:best‐4:worst) and pneumonia incidence were assessed pre‐operatively and post‐operatively.Results: 62 patients underwent OpenCM (39/62(63 %)) or endoscopic CM (23/62(37 %) (8 RigidCM/15 FlexCM)). CM significantly reduced dysphagia for all approaches [OpenCM:2(2‐3)‐0(0‐0); RigidCM:2(2‐2)‐0(0‐0); FlexCM:3(3‐3)‐0(0‐0)]. FlexCM patients had significantly worse pre‐operative DS. Endoscopic CM was attempted and completed in 23/35(66 %) patients. Reasons for OpenCM conversion included inability to position the diverticular retractor due to patient body habitus (RigidCM), and the inability to position the overtube due to small ZD (FlexCM). Major post‐operative complications were rare and similar in all groups. Medium‐to‐long‐term post‐myotomy pneumonia was comparable between groups. LOS (days) was reduced for FlexCM (1(1‐2)) versus RigidCM (3(2‐6)) and OpenCM (4(3‐7)).Conclusions: CM is highly effective for treating ZD. Open and endoscopic approaches offer comparable outcomes and dysphagia resolution. FlexCM is efficacious for large ZD and can be performed in most patients irrespective of body habitus. FlexCM represents an excellent approach for large ZD, while OpenCM should be reserved for small ZD for which an overtube cannot be positioned.